ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 335766 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 335766; 2) Community: the network communities that were significantly associated with the response to NSC 335766; 3) Molecule: the relationships between components within communities and NSC 335766; 4) MDR: the compounds that were significantly associated with the NSC 335766.

NSC Compound Enrichment Correlation
NSC 722779 dabequine 0.0070787592519192 0.16870318
NSC 724562 11-(3'Aminopropylidene)-5,6-dihydro-5-oxo-2,3-dimethoxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.0070787592519192 0.62186681
NSC 724771 Null 0.0070787592519192 0.42826417
NSC 725202 Null 0.0070787592519192 0.49701728
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.0070787592519192 0.55558837
NSC 727012 (2S,3S)-3,4-Epoxy-2-(3-methoxy-5-methyl-1-naphthoyloxy)-3-methylbutanamide 0.0070787592519192 0.44834588
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0070787592519192 0.2701782
NSC 730294 Null 0.0070787592519192 0.42761553
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0070787592519192 0.43047016
NSC 745923 Null 0.0070787592519192 0.14555203
Total:145  Current:47    [First] [Prev] [Next] [Last]